John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 16,994 shares at $10.50 ($178K) on 2023-12-27, disclosed to the SEC on 2023-12-28.
Open-market sale of $178k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.50 | 8,497 | $89K | 50.0% |
| 2 | $10.50 | 8,497 | $89K | 50.0% |
| Total | $10.50 avg | 16,994 | $178K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |